Anticancer activity of 9-cis-retinoic acid encapsulated in PEG-coated PLGA-nanoparticles

Journal of Drug Delivery Science and Technology

Volumn 21, Issue 5, 2011, Pages 395-400

  Cosco, D ^a   Molinaro, R ^a   Morittu, V M ^a   Cilurzo, F ^b   Costa, N ^a   Fresta, M ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

9 cis retinoic acid; ARO cells; Cell differentiation; Drug photo stabilization; In vitro activity; PLGA nanoparticles; PTC 1 cells

Indexed keywords

ALITRETINOIN; MACROGOL; NANOPARTICLE; POLYGLACTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; IN VITRO STUDY; NANOENCAPSULATION; ZETA POTENTIAL;

EID: 80055036900     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(11)50064-4     Document Type: Article

References (39)

1. Ioele G., Cione E., Risoli A., Genchi G., Ragno G. - Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. - Int. J. Pharm., 293, 251-260, 2005. (Pubitemid 40381097)
2. Trapasso E., Cosco D., Celia C., Fresta M., Paolino D. - Retinoids: new use by innovative drug-delivery systems. - Expert Opin. Drug Deliv., 6, 465-483, 2009.
3. Klaassen I., Braakhuis B.J.M. - Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer. - Oral Oncol., 38, 532-542, 2002. (Pubitemid 34880115)
4. Garcia A.L., Rühl R., Herz U., Koebnick C., Schweigert F.J., Worm M. - Retinoid- and carotenoid-enriched diets influence the ontogenesis of the immune system in mice. - Immunology, 110, 180-187, 2003. (Pubitemid 37249257)
5. Szabova L., Macejova D., Dvorcakova M., Mostbock S., Blazickova S., Zorad S., Walrand S., Cardinault N., Vasson M.P., Rock E., Brtko J. - Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci., 72, 831-836, 2003. (Pubitemid 35449509)
6. Leelawat K., Ohuchida K., Mizumoto K., Mahidol C., Tanaka M. - All-frans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. - Cancer Lett., 224, 303-310, 2005. (Pubitemid 40725850)
7. Awisati G., Tallman M.S. - All-frans retinoic acid in acute promyelocytic leukaemia. - Best Pract. Res. Clin. Haematol., 16, 419-432, 2003.
8. Pettersson F., Dalgleish A.G., Bissonnette R.P., Colston K.W. - Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. - Br. J. Cancer, 87, 555-561, 2002.
9. Wu Q., Chen Z.M., Su W.J. - Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells. - Int. J. Biochem. Cell Biol., 34, 1102-1114, 2002. (Pubitemid 34493771)
10. Wu Q., Chen Z., Su W. - Mechanism of inhibition on activator protein-1 activity by all-trans retinoic acid in gastric cancer cells. - Chin. Med. J. (Engl.), 113, 972-976, 2000.
11. Wu Q., Chen Y.Q., Chen Z.M., Chen F., Su W.J. - Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro. - Acta Pharmacol. Sin., 23, 835-841, 2002. (Pubitemid 35012988)
12. Desai SH, Boskovic G, Eastham L, Dawson M, Niles RM. - Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells. - Biochem. Pharmacol., 59, 1265-1275, 2000. (Pubitemid 30157889)
13. Adachi Y., Itoh F., Yamamoto H., Iku S., Matsuno K., Arimura Y, Imai K. - Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer. - Tumour Biol., 22, 247-253, 2001. (Pubitemid 32588920)
14. Lovat P.E., Irving H., Malcolm A.J., Pearson A.D., Redfern CR - 9-cis retinoic acid: a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma. - J. Neurooncol., 31, 85-91, 1997. (Pubitemid 27077712)
15. Vuligonda V., Lin Y., Thacher S.M., Standeven A.M., Kochar D.M., Chandraratna R.A.S. - A new class of RAR subtype selective retinoids: correlation of pharmacological effects with receptor activity. - Bioorg. Med. Chem., 7, 263-270, 1999. (Pubitemid 29117088)
16. Sinico C., Manconi M., Peppi M., Lai F., Valenti D., Fadda A.M. - Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. - J. Control. Rel., 103, 123-136, 2005. (Pubitemid 40248567)
17. Laquintana V, Denora N, Musacchio T, Lasorsa M, Latrofa A, Trapani G. - Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents. - J. Control. Rel., 137, 185-195, 2009.
18. Licciardi M., Cavallaro G., Di Stefano M., Fiorica C., Giammona G. - Polyaspartamide-graft-polymethacrylate nanoparticles for doxorubicin delivery. - Macromol. Biosci., 11, 445-454, 2011.
19. Anderson J.M, Shive S.S. - Biodegradation and biocompatibility of PLA and PLGA microspheres. - Adv. Drug Deliv. Rev., 28, 5-24, 1997. (Pubitemid 27497671)
20. Fattal E., Vauthier C. - Nanoparticles as drug delivery systems. - In: Encyclopedia of Pharmaceutical Technology, Marcel Dekker, NewYork, 2002, pp. 1864-1882.
21. Pereira M.A., Furtado V.C., Carneiro J.M., Spangler M., Andrade G., Nascimento V. - PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy. - Eur. J. Pharm. Sci., 33, 42-51, 2008. (Pubitemid 350235191)
22. Díaz-López R., Tsapis N., Santin M., Bridal S.L., Nicolas V., Jaillard D., Libong D., Chaminade P., Marsaud V., Vauthier C., Fattal E. - The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. - Biomaterials, 31, 1723-1731, 2010.
23. Betancourt T, Brown B., Brannon-Peppas L. - Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. - Nanomedicine (London), 2, 219-232, 2007. (Pubitemid 46845768)
24. ICH Harmonized Tripartite Guideline. - Photostability Testing of New Drug Substance and Products. - Federal Register, 62, 27115-27122, 1996.
25. Celia C., Malara M.,Terracciano R., Cosco D, Paolino D., Fresta M., Savino R. - Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells. - Nanomedicine, 4, 155-166, 2008.
26. Cosco D, Paolino D, Muzzalupo R, Celia C, Citraro R, Caponio D, Picci N, Fresta M. - Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. - Biomed. Microdevices, 11, 1115-1125, 2009.
27. nd ed., J.G. Webster Ed., John Wiley & Sons, 2006, pp.437-495.
28. Schmutzler C., Köhrle J. - Retinoic acid redifferentiation therapy for thyroid cancer. - Thyroid, 10, 393-406, 2000. (Pubitemid 30418744)
29. Schmutzler C., Hoang-Vu C., Rüger B., Köhrle J. - Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. - Eur. J. Endocrinol., 150, 547-556, 2004. (Pubitemid 38584707)
30. Schmutzler C., Schmitt T.L., Glaser F., Loos U., Köhrle J. - The promoter of the human sodium/iodide-symporter gene responds to retinoic acid. - Mol. Cell. Endocrinol., 189, 145-55, 2002. (Pubitemid 34229172)
31. Simon D., Körber C., Krausch M., Segering J., Groth P., Görges R., Grünwald F., Müller-Gärtner H.W., Schmutzler C., Köhrle J., Roher H.D., Reiners C. - Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. - Eur. J. Nucl. Med. Mol. Imaging, 29, 775-782, 2002.
32. Love W.K., Berletch J.B., Andrews L.G., Tollefsbol T.O. - Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells. - Int. J. Oncol., 32, 625-631, 2008. (Pubitemid 351330469)
33. Hong T.K., Lee-Kim Y.C. - Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells. - Nutr. Res. Pract., 3, 77-83, 2009.
34. Liu J., Qiu Z., Wang S., Zhou L., Zhang S. - A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. - Biomed. Mater., 5, 065002, 2010.
35. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. - Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. - J. Colloid Interface Sci., 351, 19-29, 2010.
36. Tallman M.S. - Differentiating therapy with all-frans retinoic acid in acute myeloid leukemia. - Leukemia, 10, S12-15, 1996. (Pubitemid 26146243)
37. Jiang A.L, Zhang P.J., Chen W.W., Liu W.W., Yu C.X., Yu X.Y., Zhang X.Q., Zhang J.Y. - Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaR - Asian J. 7ndrol., 8, 435-441, 2006.
38. Douer D, Estey E, Santillana S, Bennett J.M., Lopez-Bernstein G., Boehm K., Williams T - Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-frans retinoic acid. - Blood, 97, 73-80, 2001. (Pubitemid 32061244)
39. Cosco D., Paolino D., Maiuolo J., Russo D, Fresta M. - Liposomes as multicompartimental carriers forthe multidrug delivery in anticancer chemotherapy. - Drug Deliv. and Transl. Res., 1, 66-75, 2011.